Cita APA

Guo, H., Liu, F., Yang, S., & Xue, T. (2020). Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression. Oncol Lett.

Citación estilo Chicago

Guo, Hongchun, Feng Liu, Shuguang Yang, y Tao Xue. "Emodin Alleviates Gemcitabine Resistance in Pancreatic Cancer By Inhibiting MDR1/P-glycoprotein and MRPs Expression." Oncol Lett 2020.

Cita MLA

Guo, Hongchun, Feng Liu, Shuguang Yang, y Tao Xue. "Emodin Alleviates Gemcitabine Resistance in Pancreatic Cancer By Inhibiting MDR1/P-glycoprotein and MRPs Expression." Oncol Lett 2020.